Qurient Co Ltd

115180

Company Profile

  • Business description

    Qurient Co Ltd is a South Korea based biotech company. It is engaged in network research & development business model, integrating research and drug development programs with a new mechanism. Its pipeline products include Q301 for the treatment of atopic dermatitis; Q203 treats MDR/XDR/TDR TB, and Q701 is a drug-resistant cancer immuno-oncology.

  • Contact

    C-dong 8th Floor, 242, Pangyo-ro
    Bundang-gu
    Seongnam-siGyeonggi-do13487
    KOR

    T: +82 3180601600

    http://www.qurient.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 December 2025

    Employees

    30

Stocks News & Analysis

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,637.8012.900.15%
CAC 407,789.461.360.02%
DAX 4023,972.8165.38-0.27%
Dow JONES (US)42,101.572.870.01%
FTSE 1008,726.320.310.00%
HKSE23,573.38315.071.35%
NASDAQ19,244.89143.950.75%
Nikkei 22538,432.98710.581.88%
NZX 50 Index12,281.3180.95-0.65%
S&P 5005,913.0224.470.42%
S&P/ASX 2008,409.8012.900.15%
SSE Composite Index3,363.4523.510.70%

Market Movers